Latest filing published 27 Jun 2019 for Minerva Neurosciences, Inc., €49k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -38.1%Entry US$45.04 · Close at T+365 US$27.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Hans Peter Hasler: trading record in brief
Filings by Hans Peter Hasler span 3 companies, the busiest being Biogen Inc., Patheon N.V. and Minerva Neurosciences, Inc. The record holds 101 filings, for trades running from 6 February 2007 to 26 June 2019.
On the open market, the record shows 1 purchase worth €49k and 69 sales worth €12.0M. Netting one side against the other leaves €12.0M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 18 share grants and 12 option exercises. In 2019 alone, the filings show 1 purchase and no sales.
The latest filing, published on 27 June 2019, reports an open-market purchase of €49k in Minerva Neurosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hans Peter Hasler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$5.60100.0% of flowCommon StockSEC:0001209191-19-039268:0Canonical exit: 24 Sept 2019 (T+90)
- 16,864 shares@ US$35.0090.7% of flowRestricted Stock Units (Ordinary Shares)SEC:0001209191-17-050804:0
- 6,229 shares0Restricted Stock Units (Ordinary Shares)SEC:0001226286-17-000002:0
- 897 shares0Restricted Stock Units (Ordinary Shares)SEC:0001226286-17-000002:1
- 11,905 shares0Ordinary SharesSEC:0001643848-16-000017:0
- 2,167 shares@ US$25.619.3% of flowOptions (Right to Buy)SEC:0001643848-16-000017:1
- 11,905 shares0Restricted Stock Units (Ordinary Shares)SEC:0001209191-16-133757:0
- 20,140 shares0Common StockSEC:0001127602-09-005064:0
- 5,430 shares@ US$50.93Common StockSEC:0001127602-09-004372:0
- 6,263 shares@ US$50.95Common StockSEC:0001127602-09-004372:1
- 404 shares@ US$52.61Common StockSEC:0001127602-09-003790:0
- 350 shares@ US$52.61Common StockSEC:0001127602-09-003790:1
- 5,135 shares@ US$50.77Common StockSEC:0001127602-09-003611:0
- 5,466 shares0Common StockSEC:0001127602-09-003025:0
- 331 shares@ US$52.48Common StockSEC:0001127602-09-003025:1
- 845 shares@ US$44.31Common StockSEC:0001127602-08-008925:0
- 55 shares@ US$42.55Common StockSEC:0001127602-08-008749:0
- 12,950 shares@ US$49.31Common StockSEC:0001209191-08-043551:0
- 12,950 shares@ US$69.31Common StockSEC:0001209191-08-043551:1
- 4,400 shares0Common StockSEC:0001209191-08-034778:0
- 10,225 shares@ US$44.24Common StockSEC:0001209191-08-023623:0
- 10,225 shares@ US$64.24Common StockSEC:0001209191-08-023623:1
- 6,869 shares@ US$43.50Common StockSEC:0001209191-08-023623:2
- 100 shares@ US$63.83Common StockSEC:0001209191-08-023623:3
- 300 shares@ US$63.85Common StockSEC:0001209191-08-023623:4
25 of 90 declarations
